Submitted by Anonymous (not verified) on 28 October 2025 - 15:25
Human medicines European public assessment report (EPAR): Phesgo, pertuzumab,trastuzumab, Date of authorisation: 21/12/2020, Revision: 7, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Phesgo, pertuzumab,trastuzumab, Date of authorisation: 21/12/2020, Revision: 7, Status: Authorised